AQUABOUNTY TECHNOLOGIES INC
For the period ended Dec 31, 2024. Filed Mar 27, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 27, 2025
AQB$0.93-2.8%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
Consolidated Statements of Cash Flows
| Years EndedDecember 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Operating activities | ||
| Net loss | $(149,192,660) | $(27,557,901) |
| Adjustment to reconcile net loss to net cash used in | ||
| operating activities: | ||
| Depreciation and amortization | 904,136 | 2,158,231 |
| Share-based compensation | 299,417 | 542,265 |
| Long-lived asset impairment | 129,826,403 | — |
| Other non-cash items | 43,393 | 16,604 |
| Changes in operating assets and liabilities: | ||
| Inventory | 1,723,559 | 546,847 |
| Prepaid expenses and other assets | 1,277,535 | 375,430 |
| Accounts payable and accrued liabilities | 614,562 | (50,602) |
| Accrued employee compensation | 640,679 | (267,119) |
| Net cash used in operating activities | (13,862,976) | (24,236,245) |
| Investing activities | ||
| Purchases of and deposits on property, plant and equipment | (2,929,908) | (68,889,540) |
| Proceeds from asset sales | 10,493,222 | — |
| Other investing activities | — | (3,263) |
| Net cash provided by (used in) investing activities | 7,563,314 | (68,892,803) |
| Financing activities | ||
| Proceeds from issuance of debt | 6,934,832 | 417,673 |
| Repayment of term debt | (9,598,544) | (726,140) |
| Net cash used in financing activities | (2,663,712) | (308,467) |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | (10,133) | 2,827 |
| Net change in cash, cash equivalents and restricted cash | (8,973,507) | (93,434,688) |
| Cash, cash equivalents and restricted cash at beginning of period | 9,203,869 | 102,638,557 |
| Cash, cash equivalents and restricted cash at end of period | $230,362 | $9,203,869 |
| Reconciliation of cash, cash equivalents and restricted cash reported | ||
| in the consolidated balance sheet: | ||
| Cash and cash equivalents | $230,362 | $8,203,869 |
| Restricted cash | — | 1,000,000 |
| Total cash, cash equivalents and restricted cash | $230,362 | $9,203,869 |
| Supplemental disclosure of cash flow information and non-cash transactions: | ||
| Interest paid in cash from continuing operations | $2,157,195 | $220,125 |
| Interest paid in cash from discontinued operations | $107,260 | $69,013 |
| Property and equipment included in accounts payable and accrued liabilities | $9,205,819 | $11,670,996 |
- Nature of business and organization
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.